Invention Grant
US08637014B2 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
有权
OX-2 / CD200的抗体及其在抑制免疫应答中的用途
- Patent Title: Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
- Patent Title (中): OX-2 / CD200的抗体及其在抑制免疫应答中的用途
-
Application No.: US13533546Application Date: 2012-06-26
-
Publication No.: US08637014B2Publication Date: 2014-01-28
- Inventor: Russell P. Rother , Susan Faas McKnight
- Applicant: Russell P. Rother , Susan Faas McKnight
- Applicant Address: US CT Cheshire
- Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee Address: US CT Cheshire
- Agency: Ropes & Gray LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
This disclosure provides methods and compositions for inhibiting immune responses. The disclosure also provides methods and compositions for inhibiting graft rejection and promoting or prolonging graft survival.
Public/Granted literature
- US20120321625A1 ANTIBODIES TO OX-2/CD200 AND USES THEREOF IN INHIBITING IMMUNE RESPONSES Public/Granted day:2012-12-20
Information query
